Patents by Inventor Elizabeth Comen

Elizabeth Comen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating and prognosing nonhematopoietic malignant tumors
    Patent number: 11913959
    Abstract: Provided herein are methods of treating a nonhematopoietic malignant tumor in a patient and methods of prognosing a nonhematopoietic malignant tumor in a patient, comprising administering to the patient a therapeutically effective amount of an agent that preferentially kills or inhibits proliferation or activity of leukocytes relative to nonhematopoietic cells.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: February 27, 2024
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Larry Norton, Ross Levine, Maria Kleppe, Elizabeth Comen
  • METHODS OF TREATING AND PROGNOSING NONHEMATOPOIETIC MALIGNANT TUMORS
    Publication number: 20210263035
    Abstract: Provided herein are methods of treating a nonhematopoietic malignant tumor in a patient and methods of prognosing a nonhematopoietic malignant tumor in a patient, comprising administering to the patient a therapeutically effective amount of an agent that preferentially kills or inhibits proliferation or activity of leukocytes relative to nonhematopoietic cells.
    Type: Application
    Filed: March 19, 2021
    Publication date: August 26, 2021
    Inventors: Larry Norton, Ross Levine, Maria Kleppe, Elizabeth Comen
  • Methods of treating and prognosing nonhematopoietic malignant tumors
    Patent number: 10962543
    Abstract: Provided herein are methods of treating a nonhematopoietic malignant tumor in a patient and methods of prognosing a nonhematopoietic malignant tumor in a patient, comprising administering to the patient a therapeutically effective amount of an agent that preferentially kills or inhibits proliferation or activity of leukocytes relative to nonhematopoietic cells.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: March 30, 2021
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Larry Norton, Ross Levine, Maria Kleppe, Elizabeth Comen
  • Methods of Treating and Prognosing Nonhematopoietic Malignant Tumors
    Publication number: 20170363635
    Abstract: Provided herein are methods of treating a nonhematopoietic malignant tumor in a patient and methods of prognosing a nonhematopoietic malignant tumor in a patient, comprising administering to the patient a therapeutically effective amount of an agent that preferentially kills or inhibits proliferation or activity of leukocytes relative to nonhematopoietic cells.
    Type: Application
    Filed: December 4, 2015
    Publication date: December 21, 2017
    Applicant: Memorial Sloan Kettering Cancer Center
    Inventors: Larry Norton, Ross Levine, Maria Kleppe, Elizabeth Comen